1982•PubMedRequires access

[Treatment of Parkinson's syndrome].

Tarik Zukić

Open publisher page 0 citations

Abstract

This paper discuss other possible approaches to the treatment od Parkinson's disease and parkinsonism, particularly in the case of younger patients. There is no doubt that levodopa treatment has the major advance in the clinical management of parkinsonism patients. However, the artificially of the levodopa decreases after several years and motor complications appear. Precise diagnosis and estimated degree of disease are used before any treatment of parkinsonism. Antiholineregigs or amantadine or dopamine agonists such as pergolide and bromcriptone are highly affective and they can delay the need for the levodopa.

About this research paper

What this paper is about

This paper discuss other possible approaches to the treatment od Parkinson's disease and parkinsonism, particularly in the case of younger patients. There is no doubt that levodopa treatment has the major advance in the clinical management of parkinsonism patients. However, the artificially of the levodopa decreases after several years and motor complications appear. Precise diagnosis and estimated degree of disease are used before any treatment of parkinsonism. Antiholineregigs or amantadine or dopamine agonists such as pergolide and bromcriptone are highly affective and they can delay the need for the levodopa.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This paper discuss other possible approaches to the treatment od Parkinson's disease and parkinsonism, particularly in the case of younger patients. There is no doubt that levodopa treatment has the major advance in the clinical management of parkinsonism patients. However, the artificially of the levodopa decreases after several years and motor complications appear. Precise diagnosis and estimated degree of disease are used before any treatment of parkinsonism. Antiholineregigs or amantadine or dopamine agonists such as pergolide and bromcriptone are highly affective and they can delay the need for the levodopa.

Key concepts: Pergolide, Levodopa, Parkinsonism, Amantadine, Parkinson's disease, Medicine, Disease, Dopamine

Related papers

Back to paper searchBrowse research topicsOriginal source
[Treatment of Parkinson's syndrome]. — Research Paper | ScholarLens